Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from HUM

3 Stocks to Target as Investors Rotate Back Into the Health Care Sector

Investors seem to show renewed interest in the healthcare sector as COVID-19 cases rise worldwide and portfolio resiliency amid the uncertain macro environment. So, fundamentally strong healthcare stocks Cigna Corp (CI), Centene Corp (CNC), and Humana (HUM) might be solid buys now. Read on.

StockNews.com

3 Winning Healthcare Stocks to Buy for the Rest of the Summer

Increased health awareness and the rapidly aging population are expected to drive the growth of healthcare companies. Healthcare stocks Cigna Corp. (CI), Humana (HUM), and McKesson Corp. (MCK) have bucked the market downtrend and are in momentum. Since the market is expected to remain under pressure in the near term,…

StockNews.com

Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 11.85% on an annualized basis producing an average annual return of 18.87%. Currently, Humana has a market capitalization of $59.29 billion.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What Are Whales Doing With Humana

A whale with a lot of money to spend has taken a noticeably bullish stance on Humana. Looking at options history for Humana (NYSE:HUM) we detected 10 strange trades.

Benzinga

IBD Stock Of The Day Hails From Same Group For 3rd Day: Humana Flashes Buy Signals

Humana is the latest health insurer to be Stock Of The Day. HUM stock cleared early entries as it nears an official buy point from a long base.

Investors Business Daily

3 Stocks That Are Thriving With Higher Rates

Rising rates are a headwind for most stocks. However, for a handful, they are leading to an earnings boom,. Here are 3 stocks benefitting from higher rates: Humana (HUM), Everest RE (RE), and Silvercrest Asset Management (SAMG).

StockNews.com

Where Humana Stands With Analysts

Humana (NYSE:HUM) has observed the following analyst ratings within the last quarter:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

3 Defensive Stocks to Outperform in this Bear Market

While the stock market has entered a bear phase following the release of multi-decade high inflation data, the health insurance industry could survive the downturn because of the near-inelastic demand for health coverage. Therefore, investors looking to dodge a market downturn could bet on fundamentally sound health insurance stocks Anthem…

StockNews.com

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,500 Today

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.8% on an annualized basis producing an average annual return of 17.56%. Currently, Humana has a market capitalization of $53.98 billion.

Benzinga

5 Life Insurance Stocks to Buy Hand Over Fist

U.S. Treasury yields rose to multi-year highs earlier this month. And rising Treasury yields along with the Fed’s interest rate hikes bode well for life insurance companies. Thus, we think the shares of fundamentally sound life insurance companies Anthem (ANTM), Cigna Corp. (CI), UnitedHealth Group (UNH), Molina Healthcare (MOH), and…

StockNews.com

5 Outperforming Health Insurance Stocks Rated 'Strong Buy'

Demand for health insurance policies has soared over the past couple of years and is projected to continue rising amid heightened health awareness in the post-pandemic era. Thus, we think the stocks of quality health insurance companies Humana (HUM), Cigna (CI), Centene (CNC), Molina Healthcare (MOH), and Anthem (ANTM) could…

StockNews.com

If You Invested $1000 In Humana 20 Years Ago, Here's How Much You Would Have Today

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.96% on an annualized basis producing an average annual return of 17.93%. Currently, Humana has a market capitalization of $54.86 billion.

Benzinga

Exxon Mobil, General Dynamics Lead Five Stocks Near Buy Points Without This Big Risk

Exxon Mobil and General Dynamics are among five stocks near buy points from strong groups that have already reported earnings.

Investors Business Daily

Expert Ratings for Humana

Over the past 3 months, 6 analysts have published their opinion on Humana (NYSE:HUM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Humana's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Humana (NYSE:HUM) earned $930.00 million, a 7253.85% increase from the preceding quarter. Humana also posted a total of $24.08 billion in sales, a 13.59% increase since Q4.

Benzinga

Humana Q1 Earnings Beats Expectations, Raises FY22 Profit Guidance

Humana Inc (NYSE:HUM) has posted Q1 adjusted sales of $24.08 billion, beating the consensus of $23.51 billion. The benefits expense ratio increased from 86.4% to 85.9%, and the operating cost ratio increased from 12% to 9.7%. Humana posted an adjusted EPS of $8.04, beating the consensus of $6.78 and $6.38 posted a…

Benzinga

Humana: Q1 Earnings Insights

Humana (NYSE:HUM) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Humana to Offload Substantial Stake In Kindred At Home Hospice & Personal Care Divisions

Humana Inc (NYSE:HUM) has agreed to divest a majority interest in the Hospice and Personal Care divisions of Humana's Kindred at Home (KAH Hospice) subsidiary to Clayton, Dubilier & Rice (CD&R). The divisions include patient-centered services for Hospice, Palliative, Community, and Personal Care. Humana had previously indicated its intent to divest a majority…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

If You Invested $100 In Humana 10 Years Ago, Here's How Much You Would Have Today

Humana (NYSE:HUM) has outperformed the market over the past 10 years by 5.55% on an annualized basis producing an average annual return of 18.03%. Currently, Humana has a market capitalization of $59.08 billion.

Benzinga

UBS Upgrades Rating to Buy for Humana, Raises Price Target To $520

UBS upgraded its rating of Humana (NYSE:HUM) to Buy with a price target of $520.00, changing its price target from $486.00 to $520.00. Shares of Humana are trading up 2.2% over the last 24 hours, at $458.92 per share. A move to $520.00 would account for a 13.31% increase from…

Benzinga

This Favorable Sign Appears On Humana's Chart

If history is any guide, there may be good fortune ahead for shares of Humana (NYSE:HUM). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga

Here's How Much You Would Have Made Owning Humana Stock In The Last 5 Years

Humana (NYSE:HUM) has outperformed the market over the past 5 years by 1.74% on an annualized basis producing an average annual return of 15.84%. Currently, Humana has a market capitalization of $55.72 billion.

StockNews.com

5 Undervalued Insurance Stocks to Buy Right Now

Inflation has surged to multi-year highs, so the Fed is contemplating raising interest rates aggressively this year. And an increasing interest rate environment typically translates to revenue growth for financial companies, including insurers. Thus, we think it could be wise to bet on quality insurance stocks Cigna (CI), Humana (HUM),…

Benzinga

If You Invested $100 In This Stock 10 Years Ago, Here's How Much You Would Have Today

Humana (NYSE:HUM) has outperformed the market over the past 10 years by 5.66% on an annualized basis.

StockNews.com

Forget Clover, Buy These 4 Healthcare Plan Stocks Instead

The pandemic-driven increase in health awareness and rising chronic diseases should drive the healthcare-plans industry’s growth. However, not all industry participants are well-positioned to gain in the near term. Clover Health (CLOV), with inconsistent financials and growth, is not expected to perform well. Therefore, fundamentally sound stocks in this space—UnitedHealth…

1 2 3 4 5

People

Dipanjan BanchurSince

722 stories

Jaimini DesaiJaimini

62 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.